ARCHIVES

In Phase II Study, NKTR-102 Shows Objective Response

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Republican Contenders Slam FDA Decision In Care Of Boy With Treatable Brain Tumor.

February 4, 2000

In Brief: Kennedy, Waxman May Agree On Simple Extension Of Biomedical Research Authority, Including NCI

November 21, 1980

ASCO Breaks Ground For New HQ.

August 4, 2006

Rauscher Labels With Congress, Says NCI Needs More Money

May 2, 1975

MDV3100 Improves Survival, Reduces Death Risk by 37%

November 25, 2011

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002